+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
INDRANIB INDRANIB

Indrayani Biotech Share Price

₹7.39 -0.47 (-5.98%)
59.06% Fall from 52W High

17 Aug, 2026 4:00 PM (IST)

Indrayani Biotech live price: ₹7.39. It opened at ₹8 vs previous close ₹8; intraday high/low: ₹8/₹7. The 50 & 200 DMA stand at ₹8.60/₹11.60.

Indrayani Biotech Performance

  • Today's Low
  • ₹7
  • Today's High
  • ₹8
  • 52 Week Low
  • ₹7
  • 52 Week High
  • ₹18
  • Open Price₹8
  • Previous Close₹8
  • Volume137,780
  • 50 DMA₹8.60
  • 100 DMA₹9.50
  • 200 DMA₹11.60

Indrayani Biotech Chart

Investment Returns

  • Over 1 Month -3.4%
  • Over 3 Month -30.41%
  • Over 6 Month -19.5%
  • Over 1 Year -49.03%

Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!

Invest Now

Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.2
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 0.5
  • Average True Range
  • 0.7
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.3
  • RSI
  • 38.1
  • MFI
  • 58.05

Latest Stock News Updates

Indrayani Biotech Ltd - 526445 - Board Meeting Outcome for Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31St March 2026 Along With Report Of Statutory Auditors.

Audited Standalone & consolidated financial results for the quarter and year ended 31st March 2026 along with report of statutory auditors.

Indrayani Biotech Ltd - 526445 - Results-Delay in Financial Results

Audited Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with auditors report.

Indrayani Biotech Ltd - 526445 - Board Meeting Intimation for Board Meeting Intimation For Intimation For Board Meeting To Be Held On 17Th August, 2026

Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve the audited financial results (Standalone and consolidated) for the quarter and year ended on 31st March, 2026

Indrayani Biotech Financials

Indrayani Biotech Technicals

EMA & SMA

Current Price
₹7.39
-0.47 (-5.98%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹7.90
  • 50 Day
  • ₹8.60
  • 100 Day
  • ₹9.50
  • 200 Day
  • ₹11.60

Resistance and Support

7.6 Pivot Speed
  • R3 9.40
  • R2 8.90
  • R1 8.00
  • S1 6.70
  • S2 6.20
  • S3 5.30

Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-17 Audited Results
2026-04-09 Scheme of Arrangement
2026-02-26 Quarterly Results
2025-12-11 Quarterly Results
2025-08-30 Others Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters.

Indrayani Biotech Shareholding Pattern

63.94%
32.92%
3.13%

About Indrayani Biotech

Indrayani Biotech is in the business of providing Catering services in India, involving production and sale/service of food items. View More
  • NSE Symbol
  • INDRANIB
  • BSE Symbol
  • 526445
  • ISIN
  • INE007C01021

Similar Stocks to Indrayani Biotech

Indrayani Biotech FAQs

Indrayani Biotech share price is ₹7 As on 18 August, 2026 | 01:57

The Market Cap of Indrayani Biotech is ₹39.7 Cr As on 18 August, 2026 | 01:57

The P/E ratio of Indrayani Biotech is 23.2 As on 18 August, 2026 | 01:57

The PB ratio of Indrayani Biotech is 0.5 As on 18 August, 2026 | 01:57

The 52 week High & Low of Indrayani Biotech is ₹18/₹6.7 respectively As on 18 August, 2026 | 01:57

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23